baber/WOPTO huggingface dataset:
Patent PT-881966-E (PT)
Inventor: FORLONI ROBERTO
IPC: B32B27/08
Filed: 1997-02-14
Abstract: A thermoplastic multilayer packaging film has a core layer including ethylene/vinyl alcohol copolymer; two outer layers, and two adhesive layers each disposed between the core layer and a respective outer layer, characterized in that at least one of the outer layers includes a blend of A, B, and C, wherein component A is a homogeneous or heterogeneous ethylene/alpha olefin copolymer with density comprised greater than 0.915 g/cm3 and less than 0.925 g/cm3, component B is a homogeneous or heterogeneous ethylene/alpha olefin copolymer with density greater than or equal to 0.925 g/cm3, and component C is a homogeneous or heterogeneous ethylene/alpha olefin copolymer with density less than or equal to 0.915 g/cm3. The use of modified homogeneous ethylene/alpha olefin copolymers with a density of from 0.900 g/cm3 to 0.908 g/cm3 as adhesive layers to improve the interlayer adhesion and the sealability properties of films with a core layer comprising an ethylene/vinyl alcohol copolymer or a polyamide and outer layers comprising an ethylene/alpha olefin copolymer is also described.
Patent PT-932682-E (PT)
Inventor: RUPAR MARK J
IPC: A01N63/50
Filed: 1997-09-25
Abstract: Disclosed is a novel ´-endotoxin, designated CryET29, that exhibits insecticidal activity against siphonopteran insects, including larvae of the cat flea ( Cteno-cephalides felis),  as well as against coleopteran insects, including the southern corn rootworm  (Diabrotica undecimpunctata),  western corn rootworm ( D. virgif-era ) ,  Colorado potato beetle ( Leptinotarsa decemlineata ) ,  Japanese beetle ( Popil-lia japonica ) ,  and red flour beetle ( Tribolium castaneum ) .  Also disclosed are nucleic acid segments encoding CryET29, recombinant vectors, host cells, and transgenic plants comprising a  cryET29  DNA segment. Methods for making and using the disclosed protein and nucleic acid segments are disclosed as well as assays and diagnostic kits for detecting  cryET29  and CryET29 sequences  in vivo  and  in vitro.
Patent PT-999764-E (PT)
Inventor: MULLER KARL
IPC: A43B13/12
Filed: 1998-07-03
Abstract: A shoe includes a sole (2) that extends from a rear heel area (6) through a metatarsal area (7) to a front ball or toe area (8), the sole being composed of a sole body (10) and a sole covering (11) formed on the underside of the sole body (10) and a recess (13) extending approximately from metatarsal area (7) to heel area (6). The recess is provided between sole body (10) and sole covering (11), with the area of sole covering (11) associated with recess (13) forming a pivoting element (18) designed to pivot around a pivot axis (20) located in the end area of recess (13) facing metatarsal area (7). The end area of recess (13) facing metatarsal area (7) is defined by a tip (13a) of recess (13), and the pivot axis (20) is located in the area between a lengthwise center of shoe (1) and heel area (6), with heel area (6) extending over approximately one-third of the length of shoe (1). At least one material element (25) is located in recess (13), the material element (25) being made of a flexible, soft material and being made approximately wedge-shaped or approximately in the shape of a circular section.
Patent PT-1017667-E (PT)
Inventor: FORESTA PIERO
IPC: A61P29/00
Filed: 1998-09-22
Abstract: 2-Aminotetralines, a process for their preparation, and pharmaceutical compositions, for the prevention and therapeutic treatment of inflammatory pathologies (particularly septic shock) and/or autoimmune pathologies in which the aetiopathogenic role of inflammatory cytokines has been ascertained.
Patent PT-941944-E (PT)
Inventor: LUCANO ROSARIA
IPC: B65D85/32
Filed: 1999-03-01
Abstract: The egg box consists of a base of a thermoformed synthetic material and a lid of cardboard. The base has six cells (12), each made to receive one egg, and at least one of the cells has a rigid base (14) and a deformation zone (16) to facilitate the removal of the first egg from a full box. The rigid base has a flat circular portion in the middle surrounded by concentric ribs (20), while the deformation zone comprises a flat outer ring (24) and ribs between it and the cell wall.
Patent SG-36891-G (SG)
Title: Disposable waste-containment garment
IPC: A61F13/539
Filed: 1991-05-13
Abstract: A disposable waste-containment garment such as a disposable diaper, an external incontinent protection garment for adults (e.g. adult incontinent briefs), an external catamenial, or a disposable liner for either a disposable diaper or an incontinent brief. The garment, which may be elasticized by, for example, having elasticized leg cuffs and waistbands, comprises an absorbent core comprising substantially unbonded fibers disposed between a liquid permeable lamina and a liquid impermeable backsheet, and the liquid permeable lamina and the absorbent core are bonded together in face to face relation with an open pattern of adhesive: preferably a fine scale reticulated network of filaments of pressure sensitive hot melt adhesive having a weight of from about one-half (½) milligram to about three (3) milligrams per square inch (from about 0.8 to about 4.7 grams per square meter) but, more preferably, from about one-and-three-tenths (1.3) milligrams to about two-and-three-tenths (2.3) milligrams per square inch (from about 2.0 to about 3.6 grams per square meter) and, most preferably, about two (2) milligrams per square inch (about 3.1 grams per square meter). In a preferred embodiment of such a garment, the liquid permeable lamina is a portion of a wet-strength-tissue envelope in which the absorbent core is disposed and secured; and the core further comprises elements of highly liquid absorbent matter which elements may be fibrous or particulate or the like in form. Additionally, such garments may further comprise additional laminae which may also be adhesively secured together or to the above enumerated elements: preferably in the manner in which the lamina described above is adhesively secured to the absorbent core.
Patent IE-790041-L (IE)
Title: Pull-out blank in a metal cabinet wall
IPC: B21D51/38
Filed: 1979-01-10
Abstract: A pull-out blank for creating an opening in a cabinet wall (1) is composed of a pair of parallel-running score lines (2, 3) surrounding the blank proper. The strip (4) defined by the score lines (2, 3) is transversely scored in at least one place (5), providing a weak spot that may be punched with a pointed tool in order to force one end of the strip (4) away from the sheet metal (1). A pair of pliers may be used to pull the strip (4) out of the cabinet wall (1), whereby the blank proper is also removed.
[EP0003131A2]
Patent IE-37168-L (IE)
Title: Foam for sweetmeats.
IPC: A23P30/40
Filed: 1973-01-30
Abstract: In the preparations of sweetmeat products with a foamed or cellular structure from albumen and sugar, the foamed product is hardened by treatment with alcohol. This confers an increased shelf-life on the product and avoids the spoilage which occurs when the hardness is produced by heating at an elevated temperature.
[US3873754A]
Patent IE-790188-L (IE)
Title: Reclosable containers
IPC: B65D43/02
Filed: 1979-01-31
Abstract: A container comprising a metal container body having an access aperture with a curled rim and a cap for closing the access aperture with the latter carrying a plurality of radially projecting projections and the curled rim of the container body having recesses therein, portions of the curled rim being radially flattened to provide the recesses and leave adjacent thereto rim portions under which the projections of the cap can engage, the recesses being arranged to permit passage of the cap projections therethrough upon bringing the cap axially up to the access aperture, and the cap projections being arranged to engage under the rim portions adjacent the recesses when the cap is then turned, so as to secure the cap on the container body.
[US4202462A]
Patent IE-780257-L (IE)
Title: Machine tool testing
IPC: G05B23/02
Filed: 1978-02-06
Abstract: An analog signal which occurs in a computer controlled machine tool is converted to digital form at the machine tool site and is stored in a memory portion of the machine tool computer. The digitized analog signal is subsequently read out of the memory and is transmitted to a remote diagnostic unit via a conventional digital transmission link. The digitized analog signal received by the diagnostic unit is stored in a memory portion of the diagnostic computer and is subsequently read out and converted back to analog form for display on an oscilloscope in the diagnostic unit to aid in the diagnosis of existing or incipient faults in the machine tool.[US4109309A]
Patent IE-37542-L (IE)
Title: Pressure sensitive recording.
IPC: B41M5/155
Filed: 1972-03-08
Abstract: A pressure sensitive recording developer sheet comprising a phenolic resin developer coating on a support, the improvement which comprises said phenolic resin developer being a resin which is obtained by modifying with an alkylphenol compound represented by the general formula WHEREIN R1+L, R2 and R3 which may be the same or different each represents a hydrogen atom or an alkyl group with the proviso that they simultaneously should not be hydrogen atoms, in the condensation of p-phenyl phenol and aldehyde. The coating may also contain microcapsules containing a substantially colorless coupler.
[US3857721A]
Patent IE-880599-L (IE)
Title: High drug:lipid formulations of liposomal-antineoplastic¹agents
IPC: B01J13/02
Filed: 1988-03-03
Abstract: A method for encapsulation of antineoplastic agents in liposomes is provided, having preferably a high drug:lipid ratio. Liposomes may be made by a process that loads the drug by an active mechanism using a transmembrane ion gradient, preferably a transmembrane pH gradient. Using this technique, trapping efficiencies approach 100%, and liposomes may be loaded with drug immediately prior to use, eliminating stability problems related to drug retention in the liposomes. Drug:lipid ratios employed are about 3-80 fold higher than for traditional liposome preparations, and the release rate of the drug from the liposomes is reduced. An assay method to determine free antineoplastic agents in a liposome preparation is also disclosed.
Patent IE-900759-L (IE)
Title: Cutting guide
IPC: D06H7/02
Filed: 1990-03-02
Abstract: PCT No. PCT/GB90/00334 Sec. 371 Date Jun. 1, 1992 Sec. 102(e) Date Jun. 1, 1992 PCT Filed Mar. 5, 1990 PCT Pub. No. WO90/10526 PCT Pub. Date Sep. 20, 1990.A guide for use in cutting carpet and a method of joining two portions of cut carpet in edge-to-edge relationship has a base formed as a lower portion and an upper portion interengaged through a longitudinal slideway and presenting an upper ramp surface. The upper portion has a longitudinal channel along which a knife blade can pass to cut a carpet portion laid on the ramp. The lower portion has a vertical wall vertically below the channel and against which the cut edge of first carpet portion is located to abut during cutting of the second carpet portion on the ramp so that when the guide is removed the two cut edges will fall into edge-to-edge abutment for joining together.
Patent IE-790856-L (IE)
Title: 1,3,4-thiadiazole derivatives
IPC: C07D417/12
Filed: 1979-08-08
Abstract: Novel alkylaminopropanol derivatives of 2-methyl-5-(2-hydroxystyryl)-1,3,4-thiadiazole and their addition salts with acids, their preparation, and pharmaceutical formulations, containing these compounds, which may be used for the treatment of coronary diseases of the heart, of hypertonia and of cardiac arrhythmias.
[US4237278A]
Patent FI-830350-L (FI)
Inventor: BRINKMANN BERND
IPC: C08G18/38
Filed: 1983-02-01
Abstract: Elastic synthetic-resin compositions useful as adhesive and sealing compounds, for example, for absorbent and nonabsorbent undercoats on surfaces, are based, in particular, on polyurethane and have incorporated therein as adhesion promoters silanes containing polyoxyalkyl groups of the formula   <IMAGE>   wherein X is -SH, -NHR2,   <IMAGE>   or -(NH-CH2-CH2)b NHR2, b is 1 or 2, R is -CH3, -CH2-CH3 or -OR1, R1 is -(CH2-CH2-O)m-R3, R2 is H, an aliphatic, cycloaliphatic or aromatic hydrocarbon group each of 1 to 10 carbon atoms, or such a group which is substituted R3 is alkyl of 1 to 10 carbon atoms, or substituted alkyl of 1-10 carbon atoms, R4 is alkyl of 1 to 4 carbon atoms, n is a number from 1 to 8, m is a number from 1 to 30, p is >/= 1, and q+p is </= 2. The synthetic-resin compounds of this invention have improved adhesion to diverse substrates even without the use of adhesion-promoting coatings. This adhesion is sufficient for practical purposes and can be secured within relatively short times.
Patent FI-845088-L (FI)
Inventor: GROUILLER HERVE
IPC: A61K47/00
Filed: 1984-12-21
Abstract: The present invention relates to a new inert matrix having adjustable porosity and hardness. This matrix comprises polycaprolactone having an average molecular weight of between 2000 and 70,000, which is in the form of agglomerated grains having an average diameter of between 50 and 500  mu m and has a degree of crystallinity of at least 75%. The invention relates to the method for the preparation of a porous galenic form by means of the said matrix.
Patent IE-801019-L (IE)
Title: Composition
IPC: A61K31/485
Filed: 1980-05-16
Abstract: A composition consisting essentially of nalbuphine and acetaminophen gives unexpectedly enhanced analgesic activity.
[US4237140A]
Patent IE-37848-L (IE)
Title: Granular mixtures of fructose and glucose
IPC: C13K3/00
Filed: 1973-06-25
Abstract: A dry, granulated, free-flowing product containing a mixture of fructose and glucose, e.g. invert sugar, is prepared by first combining a fructose and glucose solution having a high dry solids content with an essentially dry, crystalline mass comprising a mixture of fructose and glucose. The admixture of solution and crystalline mass are then agitated in a relatively dry atmosphere, i.e., less than about 30 percent relative humidity, at a temperature from about 20 DEG C to about 50 DEG C to form the dry, granulated, free-flowing product.
[US3816175A]
Patent IE-781291-L (IE)
Title: Psychopharmacological peptides
IPC: A61P25/28
Filed: 1978-06-28
Abstract: Novel peptides of the formula <IMAGE> are disclosed (together with pharmaceutical compositions comprising a pharmaceutically effective amount of same) wherein X1 and X2 represent an hydroxy or amino group and B represents: (1) hydroxy or (2) an amino-acid residue selected from the group consisting of L-Asp-OH, L-Asn-OH, L-Glu-OH, L-Gln-OH, L-Ser-OH, or HN-A-COOH, wherein A is an alkylidene group from 1 to 6 carbon atoms; or a functional derivative thereof.
[US4203975A]
Patent IE-791480-L (IE)
Title: Non-return valve unit for containers
IPC: B65D49/02
Filed: 1979-08-08
Abstract: A non-return valve unit for a bottle having a mechanism for preventing dripping and for giving a controlled discharge of liquid from the bottle, suitable for use with any type of bottle neck by insertion in the said neck and especially for bottles adapted to receive "pilfer-proof" caps. The valve unit consists of only three elements made up generally of a cylindrical slightly frusto-conical body having a brim for preventing dripping and having a septum in its interior where the seat of a generally circular valve is positioned. Radial septa which support an annular guide for the stem of a check or retention valve, form a component part of this septum. An upper chamber in the body houses a pouring device of a frusto-conical shape. The pouring device has a cylindrical wall internally supported by radial septa which ends in a frusto-conical surface; and provides together with the inner cylindrical surface of the pourer a circular area of discharge. The pouring device also provides guide ridges for guiding the movement of the upper stem of the retention valve which, on moving upward rests against the lower edge of the said inner cylindrical wall. The shape of the base of retention valve being the same as that of the inner frusto-conical surface to which the assembly is connected, providing, when the valve rises for the discharge of the liquid by tilting the bottle with the inner wall of the pourer, a discharge circular space allowing a controlled discharge free of turbulence.
[US4261484A]
Patent IE-38318-L (IE)
Title: Amino-quinazoline derivatives
IPC: C07D491/056
Filed: 1973-09-03
Abstract: 1383409 Heterocyclic substituted-2- or 4- amino-quinazolines PFIZER Ltd 6 Sept 1973 [9 Sept 1972] 41992/72 Heading C2C Novel compounds of the Formula I in which each R<SP>1</SP> is a hydroxyl, benzyloxy or C 1-6 alkoxy group, and m is 1 to 3, or two of the moieties R<SP>1</SP> constituting a C 1-6 -alkylenedioxy group attached to adjacent positions of the benzene ring portion of the quinazoline nucleus; and one of A and B represents an amino group whilst the other represents a benzo-fused heterocyclic group of the formula in which each R<SP>2</SP> is a halogen atom, or a hydroxyl, C 1-6 -alkyl, C 1-6 -alkoxy, C 2-6 -alkenoxy, aryloxy, nitro, amino, acylamino or C 1-6 - alkoxycarbonylamino group, n being 1 to 3, with the proviso that (R<SP>2</SP>) n can be or contain only a single nitro, amino, acylamino or lower alkoxycarbonylamino group, or two of the moieties R<SP>2</SP> constituting a C 1-6 -alkylenedioxy group attached to adjacent positions of the benzene ring portion of the benzo-fused heterocyclic group; p and q are each 0 to 4 with the proviso that p+q equals 2 to 4; and R<SP>3</SP> is a hydrogen atom or a C 1-6 -alkyl group attached at any one of the substitutable carbon atoms of the nitrogen containing heterocyclic ring of the benzo-fused heterocyclic group; and their pharmaceutically acceptable acid addition salts may be prepared (1) except those in which (R<SP>2</SP>) n is or contains an amino group, by reacting a 2,4-dichloroquinazoline II with ammonia and a compound III (2) by interconversion of the substituent groups R<SP>1</SP> and R<SP>2</SP>, e.g. etherifying free hydroxy groups, reducing nitro groups to amino optionally followed by acylation or reaction with a C 1-6 - alkyl chloroformate ester or cleaving a benzyloxy to yield a hydroxy group or (3) by salt formation. 5,6-Dimethoxyisoindole hydrochloride may be prepared by cyclizing 4,5-di-(chloromethyl) veratrole and benzhydrylamine to yield 2- benzhydryl-5,6-dimethoxyisoindole followed by catalytic hydrogenation to remove the benzhydryl group. Pharmaceutical compositions of the compounds I with the usual excipients show antihypertensive activity when administered orally or parenterally.
[GB1383409A]
Patent IE-892031-L (IE)
Title: Detection of nuclear radiation
IPC: G01T1/11
Filed: 1989-06-22
Abstract: A method of detecting, counting or otherwise measuring nuclear radiation includes the steps of exposing a diamond containing single substitutional paramagnetic nitrogen to the nuclear radiation to cause electrons or holes to be trapped at lattice imperfections within the diamond crystal structure, heating the diamond to cause it to luminesce and utilising the luminescence as a means for the detection, counting or measurement of the nuclear radiation. The method is characterised by subjecting the diamond to a high dose of neutron or electron irradiation prior to exposing it to the nuclear radiation to be detected. This, it has been found, improves both the sensitivity of the diamond as a thermoluminescent material and linearity of the thermoluminescent response to nuclear radiation dose.
Patent IE-832037-L (IE)
Title: Iontophoretic treatment
IPC: A61N/
Filed: 1979-01-08
Abstract: A method and apparatus for applying iontophoretic treatment to a living body is provided by which a unidirectional treatment current is periodically interrupted by a relatively short pulse of current in the opposite direction in order to prevent the formation of undesirable vesicles and bulla in the skin being treated. The apparatus and method are arranged to impose the treatment current gradually at the beginning of each treatment.
[US4301794A]
Patent IE-41904-L (IE)
Title: Cinnamoylpyrandiones
IPC: C07D309/36
Filed: 1975-09-29
Abstract: 1527375 3 - (1 - Aminoethylidene) - 5 - cinnamoyl - 2H - pyran - 2,6(3H) - diones SMITHKLINE CORP 11 Sept 1975 [2 Oct 1974] 37417/75 Heading C2C The invention comprises compounds of the formula wherein R is (C 3 to C 6 ) straight or branchedchain alkyl, phenyl, halophenyl, hydroxyphenyl, methoxyphenyl, p-mercaptophenyl or aminophenyl and R 1 is H, OH, methoxy or dimethoxy; which may be obtained by reacting a compound of the formula with an aldehyde of the formula Pharmaceutical compositions useful in the treatment of allergic diseases comprise the compounds of Formula I above together with a pharmaceutical carrier. They may be administered orally, parenterally or by inhalation.
[GB1527375A]
Patent IE-882379-L (IE)
Title: Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells
IPC: A61K33/24
Filed: 1988-08-03
Abstract: This invention relates to anthracycline prodrugs allowing the delivery of cytotoxic drugs to tumor cells by the administration of a tumor-specific antibody-enzyme conjugate that binds to the tumor cells, and the additional administration of the prodrug that is converted at the tumor site, in the presence of the antibody-bound enzyme, to an active cytotoxic drug. The present invention also relates to a method for preparing these prodrugs. According to one embodiment of the invention, an antibody-enzyme conjugate containing the enzyme, penicillin V amidase ("PVA"), has been used in conjunction with a novel prodrug, N-(p-hydroxyphenoxyacetyl)adriamycin to effect killing of tumor cells. The products of this invention provide for enhanced selective killing of tumor cells and are thus useful in the treatment of cancers and other tumors.
Patent IE-822542-L (IE)
Title: MICROORGANISM ACTINOMADURA YUMAENSE SP. NOV. TO PREPARE¹ANTIBIOTICS LL-C23024Ó, ß AND IOTA.
IPC: C12R1/03
Filed: 1982-10-21
Abstract: Antibiotic LL-C23024 alpha , or a pharmaceutically acceptable salt thereof, or a fermentation broth or harvest mash solid from which the antibiotic is obtained, is used to control nematodes in warm-blooded animals or in the soil.
[GB2147808A]
Patent IE-812641-L (IE)
Title: Imidazoles
IPC: A61P9/06
Filed: 1981-11-11
Abstract: Compounds of the formula <IMAGE> wherein R is hydrogen or methyl, and non-toxic, pharmacologically acceptable acid addition salts thereof. The compounds as well as their salts are useful as bradycardiacs.
[US4409235A]
Patent IE-832648-L (IE)
Title: Thixotropic coating composition and coating method.
IPC: C09D5/08
Filed: 1983-11-14
Abstract: A stable thixotropic coating composition especially suitable for dipspin application which comprises (a) an acid binder aqueous solution which comprises phosphate ions and ions of the group of chromate ions or molybdate ions, (b) an acid-stable, non-colloidal amorphous silica and (c) a nonionic surfactant; a method for coating an article by dipspin application of said composition and parts coated therewith.
[WO8401954A1]
Patent IE-802682-L (IE)
Title: Oxazoline derivatives
IPC: C07D263/10
Filed: 1980-12-19
Abstract: Compounds of the formula <IMAGE> I wherein R1 and R2, independently, are hydrogen, halogen or lower alkyl; R3, R4, R5, R6 and R7, independently, are hydrogen or C1-3 alkyl; R8 is hydrogen, lower alkyl or formyl; R9 and R10, independently, are methyl or trifluoromethyl; and n is 0 (zero) or, when both R7 and R8 are lower alkyl, n is 0 (zero) or 1, prepared, inter alia, from p-aminobenzaldehydes which may be N-alkyl substituted, are described. The compounds of formula I are orally active antidiabetic agents.
[US4317914A]